Press ESC to close

Peptide Lab App Log in Articles News Guide Products
More Peptide Tracker Calculator Best Calculators Peptide Statistics Contact Newsletter
Français English Deutsch Español Português العربية Italiano Polski 한국어 日本語 中文 Русский Nederlands Čeština Svenska Türkçe

Peptide Encyclopedia

Our encyclopedia of the most researched peptides. Mechanisms of action, studied benefits and research status for each peptide.

60 Guide
HGH Fragment 176-191
Preclinical and early-phase research compound. Not approved for human use by any major regulator.

HGH Fragment 176-191

Human Growth Hormone C-Terminal Fragment, residues 176 to 191 (hGH 176-191)

Humanin
Preclinical research only. Not approved for human use by the FDA or EMA.

Humanin

Humanin (HN), peptide encoded within the mitochondrial MT-RNR2 (16S rRNA) region

IGF-1 LR3
Research use only. Not approved for human use by the FDA, the EMA or any comparable regulator.

IGF-1 LR3

Long R3 Insulin-like Growth Factor-1 (Long [Arg3] IGF-I)

Ipamorelin
Research Only

Ipamorelin

Growth Hormone Secretagogue

Kisspeptin
Investigational: studied in published human clinical trials, not approved as a medicine by the FDA or EMA

Kisspeptin

Kisspeptin (KISS1 gene product, also known as metastin); kisspeptin-10 is the shortest fully active fragment

KPV
Research use only — not approved for human use

KPV

Lysine-Proline-Valine (α-MSH 11-13)

Liraglutide
Approved prescription medicine (FDA, EMA, MHRA, TGA); generics available since 2024-2025

Liraglutide

Liraglutide (NN2211), N-epsilon-[gamma-glutamyl(N-alpha-hexadecanoyl)]-[Arg34]-GLP-1(7-37)

LL-37
Research use only; not approved for human therapeutic use

LL-37

Cathelicidin Antimicrobial Peptide LL-37 (hCAP-18 C-terminal fragment)

MariTide (maridebart cafraglutide, AMG 133)
Investigational. Not approved by the FDA or EMA. Phase 3 (MARITIME program) ongoing as of October 2026.

MariTide (maridebart cafraglutide, AMG 133)

Maridebart cafraglutide: fully human monoclonal anti-GIPR antagonist antibody conjugated to two GLP-1 receptor agonist analogue peptides

Matrixyl 3000
Clinically Validated

Matrixyl 3000

Palmitoyl Tripeptide-1 & Tetrapeptide-7

Mazdutide
Approved in China for chronic weight management and for type 2 diabetes. Investigational elsewhere, with no FDA or EMA approval.

Mazdutide

Mazdutide (IBI362, LY3305677), glucagon-like peptide-1 and glucagon receptor dual agonist

Research Only

Melanotan 2

Melanotan II (MT-II)